LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/LinkSPINE: First U.S. Implantation of FacetLINK MINI
Spine

LinkSPINE: First U.S. Implantation of FacetLINK MINI

August 10, 2015 2 min read Premium comments

Advertisement

LinkSPINE: First U.S. Implantation of FacetLINK MINI
FacetLINK MINI / Courtesy of LinkSPINE
Secondary

First in U.S.! LinkSPINE is announcing the first U.S. implantation of the FacetLINK MINI, a titanium device that uses two screws and an expandable cross-connector assembly to stabilize the lumbar spine after a tissue-sparing midline decompression.

Dhruv Pateder, M.D., an orthopedic spinal surgeon, performed the first U.S. MINI case at HCA Reston Hospital Center in Reston, Virginia. Dr. Pateder commented in the August 4, 2015 news release, “Using a minimally invasive technique, FacetLINK MINI allows rigid posterior spinal column fixation with only two cross-linked lag screws instead of a traditional, open pedicle screw and rod construct where four screws are needed. The FacetLINK MINI device is quickly and efficiently placed utilizing a very intuitive surgical technique. The patient is doing great and was discharged the next day.”

LinkSPINE President Massimo Calafiore stated, “FacetLINK MINI fits within the bounds of a midline decompression exposure, requiring no additional dissection beyond what was planned for the decompression itself. This is based upon the medial to lateral screw trajectories which anchor the devices to the bone, and the need for just two screws to complete a one level construct.”

As indicated in the news release, “The Facet-Link Stabilization Platform is intended to stabilize the spine as an aid to fusion through immobilization of the facet joints. The system is indicated for use with bone graft, at single or multiple levels, from L3 to S1 (inclusive). The Platform is indicated for the treatment of spondylolisthesis, degenerative disc disease as defined as back pain of discogenic origin as confirmed by radiographic studies, and degeneration of the facets with instability.”

Dr. Pateder told OTW, “I like the FacetLINK MINI device because it allows a posterior decompression and instrumented fusion (with posterior interbody fusion) without dissecting lateral to the facet joints. In my experience, this causes less post-operative pain and allows me to perform some of these cases in an ambulatory setting.”

Calafiore told OTW, “FacetLINK forms the foundation of LinkSPINE’s ‘Midline Choice’ implant platform. Additional products are under development which will integrate with FacetLINK to provide intra-operative flexibility to choose a less invasive stabilization construct based upon patient pathology, anatomy, and surgeon preference. We will continue to focus upon patient outcomes and surgeon feedback to guide our product development efforts.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy